Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal thoughts

The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines. The European Medicines Agency started investigating the…#europeanunions #novonordiskas #elilillyco #glp1 #novoswegovy #pharma #ema #lilly #trulicity #astrazenecaplcs
Source: Reuters: Health - Category: Consumer Health News Source Type: news